5 Pharmaceutical preparations for use in the treatment of malignancies; pharmaceutical preparations, namely, antitumor agents; pharmaceutical preparations for use in humans for the treatment of cancer and immunological diseases; pharmaceutical preparations for the treatment of cancer and for use in oncology and immuno-oncology